Digital pharmaceutical and medical technology company BrightInsight launched its connected diagnostics platform at the 2022 American Association for Clinical Chemistry Annual Scientific Meeting and Lab Clinic Expo.
The connected diagnostics platform includes four different tools into one platform used for in vitro diagnostics. Analytics dashboards, integration middleware, workflow portals and a proxy agent are all included in the connected digital platform, according to a July 25 news release.
"The BrightInsight connected diagnostics platform is a one-stop solution for in vitro diagnostics manufacturers to maximize workflow and visibility, manage devices more efficiently and reduce costs," said Kal Patel, MD, CEO and co-founder of BrightInsight.